Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01160588 · ClinicalTrials.gov registry record
Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 156
- Enrollment target
NCT01160588: Completed study, sponsored by University of Michigan.
NCT01160588 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01160588 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
This study will attempt to identify gene and brain activity markers that predict whether children and adolescents with anxiety disorders will respond to selective serotonin reuptake inhibitor medications or Cognitive Behavioral Therapy (CBT).
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-03 |
What the finished NCT01160588 record still lists
NCT01160588 is an observational study that tracks outcomes without assigning an intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT01160588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01160588 about?
NCT01160588 is a clinical study titled "Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents". This study will attempt to identify gene and brain activity markers that predict whether children and adolescents with anxiety disorders will respond to selective serotonin reuptake inhibitor medications or Cognitive Behavioral Therapy (CBT).
What is the current status of trial NCT01160588?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2010-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01160588?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT01160588?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia